In addition, we have tested if exposure of Ewing sarcoma cells to MI-503, a recently developed inhibitor of the MLL-menin protein-protein interaction [33, 34], impacts on tumorigenicity or posterior HOXD gene expression. The gene discussed is MEN1; the disease is Ewing sarcoma.